Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Long-Term Deferred Tax: 2011-2021

Historic Long-Term Deferred Tax for Neurocrine Biosciences (NBIX) over the last 1 years, with Sep 2021 value amounting to $310.4 million.

  • Neurocrine Biosciences' Long-Term Deferred Tax was N/A to $310.4 million in Q3 2021 from the same period last year, while for Sep 2021 it was $310.4 million, marking a year-over-year change of. This contributed to the annual value of $319.4 million for FY2020, which is N/A change from last year.
  • Neurocrine Biosciences' Long-Term Deferred Tax amounted to $310.4 million in Q3 2021, which was down 1.80% from $316.1 million recorded in Q2 2021.
  • Neurocrine Biosciences' 5-year Long-Term Deferred Tax high stood at $325.6 million for Q1 2021, and its period low was $310.4 million during Q3 2021.
  • Its 2-year average for Long-Term Deferred Tax is $317.9 million, with a median of $317.8 million in 2020.